Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Incyte Corporation    INCY

INCYTE CORPORATION

(INCY)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on INCYTE CORPORATION
10/30/19 Q3 2019 Earnings Release (Projected)
02/14/20 FY 2019 Earnings Release (Projected)
04/30/20 Q1 2020 Earnings Release (Projected)
08/04/20 Interim 2020 Earnings Release (Projected)
Past events on INCYTE CORPORATION
09/29/19 | 10:54am European Society for Medical Oncology Congress - Abstract #1621
09/29/19 | 06:00am European Society for Medical Oncology Congress - Abstract #2078
09/27/19 | 09:00am European Society for Medical Oncology Congress - Abstract #2550
09/18/19 | 07:10am Bank of America Merrill Lynch Global Health Care Conference
Upcoming sector events for INCYTE CORPORATION
10/24/19 GALAPAGOS NV : Q3 2019 Earnings Release
10/24/19 BIO-TECHNE CORP : Annual General Meeting
10/25/19 | 08:00am GALAPAGOS NV : Q3 2019 Earnings Call
10/28/19 HANGZHOU TIGERMED CONSULTING CO LTD : Q3 2019 Earnings Release (Projected)
More events
Past sector events for INCYTE CORPORATION
09/24/19 QIAGEN NV : Berenberg Goldman Sachs German Corporate Conference
09/25/19 | 09:00pm PEPTIDREAM INC : Annual General Meeting
10/07/19 | 09:30am ALNYLAM PHARMACEUTICALS, INC. : Investor Meeting - Givosiran, in Development for the Treatment of Acute Hepatic Porphyria
10/10/19 | 11:30am ALNYLAM PHARMACEUTICALS, INC. : Investor Meeting - Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type 1
Annual publications
Annual results2016201720182019 (e)2020 (e)2021 (e)
Sales
M $
Released
Forecast
Spread
1 106
1 106
0,00%
1 536
1 520
1,1%
1 882
1 844
2,1%

2 124

2 427

2 808
Operating income
(EBITDA)
M $
Released
Forecast
Spread
203
213
-4,4%
-192
-171
-12%
184
178
3,2%

439

791

950
Operating profit
(EBIT)
M $
Released
Forecast
Spread
145
158
-8,0%
-244
-209
-17%
129
105
23%

336

486

770
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
107
124
-14%
-312
-266
-17%
115
120
-3,9%

410

562

882
Net income
M $
Released
Forecast
Spread
104
122
-14%
-313
-269
-17%
109
90,8
21%

368

448

652
EPS
 $
Released
Forecast
Spread
0,54
0,62
-13%
-1,53
-1,31
-16%
0,51
0,42
21%

1,68

2,07

3,00
Announcement Date02/14/201702/15/201802/14/2019

Assessed data source
© 2019 S&P Global Market Intelligence
© 2019 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise